Advanced Health Intelligence Ltd
NASDAQ Capital MarketCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Scott Montgomery
- Full Time Employees
- 32
- Sector
- Technology
- Industry
- Software - Application
- Address
- 71-73 The Esplanade South Perth WA Australia 6151
- IPO Date
- Nov 19, 2021
- CIK
- 0001815436
- Website
- advancedhumanimaging.com
- Similar Companies
- Business
- Advanced Health Intelligence Ltd Advanced Health Intelligence Ltd (ASX:AHI) develops and provides smartphone-based biometric health assessment platforms that enable individuals to perform comprehensive digital health risk screenings using device camera sensors, computer vision, and machine learning algorithms for conditions including diabetes, obesity, hypertension, cardiovascular disease, metabolic syndrome, anxiety, and depression. The company offers core products such as Biometric Health Assessment (BHA), FaceScan for vital signs including blood pressure risk, photoplethysmography, and resting heart rate; BodyScan for anthropometric measurements, body composition analysis including waist-hip ratios and body fat percentage; predictive blood biomarker modeling for HbA1c, HDL, LDL cholesterol, and 10-year mortality risk; cardiovascular fitness evaluation and atrial fibrillation detection; on-device dermatological analysis for skin conditions including melanoma; and API integrations for customizable health reports with end-to-end encryption. Founded in 2014 and headquartered in Australia, Advanced Health Intelligence Ltd operates globally, targeting healthcare providers, insurers, employers, governments, and consumer platforms across regions including North America, Europe, the Middle East, and Asia. Recent developments include new commercialization partnerships launched in late 2024 with Vitall in Canada and Unisure in the UK for expanded digital health assessments; a collaboration agreement with IntelliGen FZ-LLC to address healthcare needs in Saudi Arabia and the Middle East; strengthened alliances with Bearn LLC in the US reaching 16 partner integrations and a potential 75 million user base, alongside Bin Farhood International Business Management Group LLC, Kalibra for precision health monitoring, OneClinic in Vietnam, and extensions with Pharmak Direct and Changlin; a US patent grant for predicting user body volume to manage medical treatment; and funding arrangements such as USD$4 million secured plus up to $5.5 million with Oakley Capital Partners Pty Ltd to support ASX reinstatement and growth.
Lilly's triple agonist, retatrutide, drove substantial improvements in weight, A1C, knee osteoarthritis pain, and obstructive sleep apnea, demonstrating its remarkable potential to treat obesity and i
DREAM Pivotal Study Data Presented at the International Surgical Sleep Society 2024 Educational Update
Advanced Health Intelligence CEO to Deliver Investor Presentation in Atlantic City
Advanced Health Intelligence Signs Binding Term Sheet with Electronic Medical Record and Global Personal Health Record Company OneClinic for Vietnam
Dr. Walid Abbas Zaher Honored as a Top Healthcare Leader by Forbes Middle East
Advanced Health Intelligence to provide Biometric Health Screening in new Collaboration between Bearn and OnCore Innovations Inc.
Advanced Health Intelligence Issues a Retraction
Advanced Health Intelligence to Play a Pivotal Role in Bearn Collaboration with AIG Insurance
Advanced Health Intelligence Ltd Selected as Finalist for Singapore Ministry of Health Project
Advanced Health Intelligence Secures Funding via Convertible Loan Facility
Advanced Health Intelligence Ltd Signs Collaboration Agreement with Bin Farhood International Business Management Group L.L.C
Advanced Health Intelligence Obtains Overseas R&D Reimbursement Under Australia's Research and Development Tax Incentive Scheme (R&DTI)
Advanced Health Intelligence to re-enter China with Exclusive License Deal with Changlin Network Technology Ltd
AHI Commentary for the Quarter Ended 30 June 2023
Advanced Health Intelligence stock rockets nearly 500% on massive volume, with no news reported
Why Is Advanced Health Intelligence (AHI) Stock Up 114% Today?
Wellteq Digital Health completes of plan of arrangement with Advanced Human Imaging
Wellteq Digital Health gets legal go-ahead for shareholder vote on acquisition by Advanced Human Imaging
Wellteq Digital Health agrees to acquisition by Australia's Advanced Human Imaging
Hot Penny Stocks To Buy For Under $5 Right Now